SCHEMBL31068680

SCHEMBL31068680

COCc1cc(Cl)cc(C=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
CYP1A2 P05177 2/20 0.39
EGFR P00533 1/20 0.39
ALDH1A1 P00352 5/20 0.38
MAPT P10636 5/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TACR2 P21452 1/20 0.37
ERN1 O75460 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
AHR P35869 1/20 0.33
ACLY P53396 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25300279 1.00 IDO1 (0.39) IDO1CYP1A2EGFRALDH1A1MAPT
SCHEMBL14536291 0.86 ERN1 (0.38) CYP1A2EGFRALDH1A1MAPTL3MBTL1
SCHEMBL3605246 0.86 ERN1 (0.38) CYP1A2EGFRALDH1A1MAPTL3MBTL1
SCHEMBL25299365 0.81 IDO1 (0.39) IDO1CYP1A2ALDH1A1MAPTL3MBTL1
SCHEMBL791863 0.80 IDO1 (0.58) IDO1ALDH1A1MAPTL3MBTL1CYP3A4
SCHEMBL15795345 0.79 HSD17B10 (0.38) CYP1A2ALDH1A1MAPTL3MBTL1CYP3A4
SCHEMBL24851930 0.78 MAOA (0.40) IDO1ALDH1A1ERN1MEN1KMT2A
SCHEMBL18003864 0.78 ALDH1A1 (0.41) IDO1CYP1A2ALDH1A1MAPTCYP2C19
SCHEMBL25370066 0.75 ERN1 (0.39) ALDH1A1MAPTERN1MEN1KMT2A
SCHEMBL30511599 0.75 ERN1 (0.39) ALDH1A1MAPTERN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118541370-A Azaindole derivatives and their use as ERK kinase inhibitors AGV探索公司 2024-08-23 CN disclosed